ClinConnect ClinConnect Logo
Search / Trial NCT06476145

Evaluating Adenoma Recurrence After Endoscopic Mucosal Resection With Margin Marking or Post Treatment With Snare Tip Soft Coagulation

Launched by ADVENTHEALTH · Jun 24, 2024

Trial Information

Current as of August 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring how often adenomas, which are non-cancerous growths in the colon, come back after a procedure called endoscopic mucosal resection (EMR). The trial is comparing two different techniques: one that marks the edges of the tissue being removed (EMR-MM) and another that uses heat to treat the edges after removal (EMR-STSC). The goal is to find out if these two methods lead to similar rates of adenoma recurrence.

If you are 18 years or older and scheduled for a colonoscopy to have a non-pedunculated polyp (a type of growth that isn’t on a stalk) that is 20 mm or larger removed, you might be eligible to participate in this study. Participants will undergo one of the two EMR techniques during their colonoscopy. It’s important to know that certain conditions, like having smaller polyps, inflammatory bowel disease, or being pregnant, may exclude someone from joining the trial. This study is currently recruiting participants, and it aims to help improve treatment options for colon polyps.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age 18 years or older
  • 2. Ability to provide informed consent
  • 3. Patient scheduled to undergo colonoscopy for the evaluation and removal of colon polyps
  • 4. Non-pedunculated polyps ≥ 20 mm size
  • Exclusion Criteria:
  • 1. Pedunculated polyps
  • 2. Inflammatory bowel disease
  • 3. Inability to provide informed consent
  • 4. Lesions \< 20 mm in size (largest dimension)
  • 5. Lesion involves the lips of the ileocecal valve, is located at the appendiceal orifice and/or is fully circumferential.
  • 6. Any standard contraindication, including pregnancy, to anesthesia and/or colonoscopy

About Adventhealth

AdventHealth is a comprehensive, faith-based healthcare organization dedicated to providing holistic care and advancing medical research through innovative clinical trials. With a commitment to improving patient outcomes and enhancing the quality of life, AdventHealth integrates cutting-edge technology and compassionate care across its extensive network of hospitals and outpatient facilities. The organization emphasizes a patient-centered approach, fostering collaboration among multidisciplinary teams to explore new treatment options and therapies. By participating in clinical research, AdventHealth aims to contribute to the advancement of medical knowledge and deliver transformative healthcare solutions to communities it serves.

Locations

Orlando, Florida, United States

Patients applied

0 patients applied

Trial Officials

Dennis Yang, MD

Principal Investigator

AdventHealth

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported